Amphastar Pharmaceuticals (AMPH) Minority Interest (2018 - 2021)

Amphastar Pharmaceuticals' Minority Interest history runs 4 years deep, the most recent figure standing at $45.2 million for Q2 2021.

• On a quarterly basis, Minority Interest changed N/A year-over-year to $45.2 million in Q2 2021; TTM through Jun 2021 was $45.2 million, a N/A change from a year earlier, with the FY2020 full-year figure at $46.4 million, up 0.55% from the prior year.
• Minority Interest held at $45.2 million in Q2 2021 per AMPH's latest filing, from $45.4 million in the prior quarter.
• Across five years, Minority Interest topped out at $46.4 million in Q4 2020 and bottomed at $21.9 million in Q3 2018.
• The 4-year median for Minority Interest is $45.3 million (2019), against an average of $42.0 million.
• Across the five-year window, Minority Interest jumped 102.47% in 2019 and declined 1.0% in 2021, its largest moves.
• Year by year, Minority Interest stood at $31.9 million in 2018, then soared by 44.6% to $46.2 million in 2019, then rose by 0.55% to $46.4 million in 2020, then dropped by 2.56% to $45.2 million in 2021.
• Per Business Quant, the three latest AMPH Minority Interest figures stand at $45.2 million (Q2 2021), $45.4 million (Q1 2021), and $46.4 million (Q4 2020).